Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 297Lung Neoplasms 195Colorectal Neoplasms 54Small Cell Lung Carcinoma 52Neoplasms 39Ovarian Neoplasms 38Melanoma 37Pancreatic Neoplasms 33Breast Neoplasms 31Neoplasm Metastasis 27Stomach Neoplasms 26Squamous Cell Carcinoma of Head and Neck 24Carcinoma, Renal Cell 22Urinary Bladder Neoplasms 20Prostatic Neoplasms 20Esophageal Neoplasms 20Endometrial Neoplasms 20Head and Neck Neoplasms 19Triple Negative Breast Neoplasms 18Colonic Neoplasms 18Uterine Cervical Neoplasms 16Carcinoma, Hepatocellular 16Mesothelioma 15Lung Diseases 13Sarcoma 12Parkinson Disease 4, Autosomal Dominant Lewy Body 12Mesothelioma, Malignant 12Adenocarcinoma of Lung 11Cholangiocarcinoma 10Rectal Neoplasms 9

Interventions

fludarabine 1aldesleukin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Adenosquamous × Thoracic × 30 days × Clear all
NCT02133196 2026-06-05

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
85 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡